iPSC-Derived Neuron Panels for Biomarker Discovery & Patient Stratification
Time: 12:10 pm
day: Conference Day One - Track One
Details:
- Developing iPSC-derived neuronal and glial models to enhance biomarker discovery and patient stratification in Alzheimer’s disease drug development
- Improving translational relevance by integrating patient-derived iPSC neuron and glial panels
- Validation of morphological and functional capabilities from the iPSC-derived neurons, astrocytes, and microglia across mono-, co-, and triculture models
- Expansion of platform into Parkinson’s Disease using Dopaminergic Neurons
